Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Praxis Precision Medicines, Inc. - Common Stock (NQ:PRAX)

44.76 -0.03 (-0.07%)
Streaming Delayed Price Updated: 11:21 AM EDT, Aug 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Praxis Precision Medicines, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Praxis Precision Medicines Announces Topline Results from the Essential1 Study of Ulixacaltamide for the Treatment of Essential Tremor and Continued Advancement of Program to Phase 3
From Praxis Precision Medicines, Inc.
Via GlobeNewswire
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
From Praxis Precision Medicines, Inc.
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off Tuesday with a look at the biggest pre-market stock movers that traders will want to keep an eye on today! 
Via InvestorPlace
Praxis Precision Outlines Upcoming Plans For Pediatric Epilepsy Programs
 
Via Benzinga
Praxis Precision Posts Disappointing Data From Depression Study
 
Via Benzinga
US Stocks Edge Lower; Bank of America Profit Tops Views
U.S. stocks traded lower this morning, with the Dow Jones dropping around 50 points on Friday. 
Via Benzinga
Praxis Precision Medicines and UCB Announce Epilepsy Research Collaboration
From Praxis Precision Medicines, Inc.
Via GlobeNewswire
Praxis Precision Medicines to Present at the American Epilepsy Society 2022 Annual Meeting
From Praxis Precision Medicines, Inc.
Via GlobeNewswire
Praxis Precision Medicines to Advance PRAX-562 Phase 2 Study in Pediatric Patients with Developmental and Epileptic Encephalopathies
From Praxis Precision Medicines, Inc.
Via GlobeNewswire
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2022 Financial Results
From Praxis Precision Medicines, Inc.
Via GlobeNewswire
Praxis Precision Medicines to Present at Upcoming Investor Conferences
From Praxis Precision Medicines, Inc.
Via GlobeNewswire
Why Laser Photonics Shares Surged By Around 19%; Here Are 70 Biggest Movers From Friday
Gainers Agrify Corporation (NASDAQ: AGFY) climbed 53.8% to close at $1.45. FedNat Holding Company (NASDAQ: FNHC) gained 48% to settle at $0.52. 
Via Benzinga
Ambit Inc. to Present Novel Projection Methodology for Rare Developmental and Epileptic Encephalopathies (DEEs) at the 2022 Child Neurology Society Annual Meeting
Ambit to showcase its prevalence projection approach, co-developed with Praxis, for rare developmental and epileptic encephalopathies (DEEs) as a Platform Presentation at this year's annual Child... 
Via Newswire.com
Needham Previews Neurocrine's Upcoming Mid-Stage Data from Essential Tremor Study
Needham previews the upcoming Phase 2 data readout for Neurocrine Biosciences Inc's (NASDAQ: NBIX) NBI-827104, a t-type calcium channel blocker in essential tremor (ET), by mid-2022. 
Via Benzinga
Tesla, Twitter And 76 Biggest Movers From Friday
Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board... 
Via Benzinga
10 Biggest Price Target Changes For Wednesday
Wells Fargo cut Lowe's Companies, Inc. (NYSE: LOW) price target from $260 to $240. Lowe's shares fell 0.7% to $194.36 in pre-market trading. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2022
Upgrades 
Via Benzinga
10 Biggest Price Target Changes For Tuesday
Keybanc cut Coupa Software Incorporated (NASDAQ: COUP) price target from $125 to $100. Coupa Software shares rose 0.9% to $72.74 in pre-market trading. 
Via Benzinga
95 Biggest Movers From Yesterday
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 100.4% to close at $4.75 on Monday after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II... 
Via Benzinga
Mid-Afternoon Market Update: Dow Turns Lower; DiDi Global Shares Surge
U.S. stocks pared gains, with the Dow Jones turning lower toward the end of trading on Monday. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Monday's session saw 84 companies set new 52-week lows. 
Via Benzinga
Mid-Day Market Update: Nasdaq Rises 1%; Praxis Precision Medicines Shares Plunge
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 1% on Monday. 
Via Benzinga
52 Stocks Moving In Monday's Mid-Day Session
Gainers DiDi Global Inc. (NYSE: DIDI) jumped 51.4% to $2.80 after the Chinese government said the company can resume adding new users. 
Via Benzinga
ROKU Stock Gets a Lift From New Spanish Streaming Section Espacio Latino
Roku (ROKU) stock is gaining on Monday after the streaming company announced a new Spanish language section named Espacio Latino. 
Via InvestorPlace
MULN Stock Fans, Mark Your Calendars for June 27
Fans of Mullen Automotive (MULN) stock are going to want to keep an eye on it when June 27 rolls around on a major catalyst. 
Via InvestorPlace
Praxis Precision Medicines (PRAX) Stock Plummets on Disappointing Study Results
Praxis Precision Medicines (PRAX) stock is taking a beating on Monday following the release of results from a recent clinical trial. 
Via InvestorPlace
Mid-Morning Market Update: Markets Open Higher; Science Applications International Earnings Top Views
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Monday. 
Via Benzinga
41 Stocks Moving In Monday's Mid-Day Session
Gainers Data Storage Corporation (NASDAQ: DTST) shares jumped 51.1% to $3.4750 after the company reported better-than-expected Q1 financial results. 
Via Benzinga
103 Biggest Movers From Yesterday
Gainers 
Via Benzinga
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.